Vedanta Biosciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Vedanta Biosciences, a leading clinical-stage microbiome company developing a new category of oral therapies using rationally defined bacterial consortia manufactured from clonal cell banks, today announced that members of its executive team will present and host one-on-one meetings at the following virtual investor conferences:
Chardan 3rd Annual Microbiome Medicines Summit
Date: Monday, March 8, 2021
Presentation Time: 2:00 PM ET
H.C. Wainwright Global Life Sciences Conference
Date: Tuesday, March 9, 2021
Presentation Time: 7:00 AM ET
Credit Suisse 2021 Healthcare Innovators Series: Life Sciences Private Company Event
Date: Thursday, March 11, 2021
Presentation Time: 12:20 PM ET
About…
